Regeneron stock price

This article explains Regeneron stock price, where to find real-time and historical quotes, what drives REGN shares, key financial and trading metrics, and how investors and traders can track movem...

2024-07-11 11:42:00

By Crypto Trailblazer

Article rating

4.2

110 ratings

Bitget offers a variety of ways to buy or sell popular cryptocurrencies. Buy now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This article covers the market price and related market-data information for Regeneron Pharmaceuticals, Inc. (ticker: REGN). You will learn where the Regeneron stock price is quoted, which data fields matter, how to view historical performance, what company and external factors drive the share price, and practical steps to track and interpret price movement using investor relations and mainstream financial platforms. The guidance is beginner-friendly and points to Bitget as a trading option for those who wish to access US equities where available.

Overview

A stock price is the current market value at which a share of a publicly traded company can be bought or sold. The Regeneron stock price refers specifically to the trading price for Regeneron Pharmaceuticals, Inc., which trades under the ticker REGN on the NASDAQ (reported in US dollars, USD). The quoted price moves continuously during market hours based on supply and demand, and is shaped by company fundamentals, macroeconomic conditions, news flow, and investor sentiment.

Company background

Regeneron Pharmaceuticals is a biopharmaceutical company focused on discovering, inventing, developing, manufacturing, and commercializing medicines for the treatment of serious medical conditions. Its business model centers on research & development, clinical development, regulatory approvals, and commercialization of biologic therapies.

Major marketed products that drive revenue and investor attention include Dupixent (for eczema, asthma, and other indications) and Eylea (for retinal disease, via collaboration). Regeneron’s product pipeline, clinical trial progress, and commercial execution all materially affect the Regeneron stock price because investors price future cash flows and risk into the share value.

Trading information

Ticker symbol and exchange

Ticker: REGN
Primary exchange: NASDAQ (National Market System)
Trading currency: USD

Trading hours and quote conventions

Regular US equity market hours: typically 09:30–16:00 ET (check current exchange calendar for holidays or early closes).
Pre-market and after-hours sessions may show additional price movement; quotes outside regular hours can be less liquid and more volatile.
Many public websites show delayed quotes (commonly 15–20 minutes) unless a real-time feed subscription is provided.

Order and lot considerations

US equities are usually traded in whole shares; fractional share trading is offered by some brokers but not all.
Common order types: market orders, limit orders, stop orders, and stop-limit orders.
Consider order routing, execution venue, and potential fees when placing trades; Bitget offers order types and execution for supported securities and can be used to manage trades and view market data.

Market data fields

Below are standard quote fields you will see when checking the Regeneron stock price and what they mean:

Last trade / Price: The most recent executed trade price for REGN.
Change: The absolute difference between the current last trade price and the previous trading session close.
% Change: Change expressed as a percentage of the previous close.
Open: The price at which the stock first traded at the start of the current session.
Previous close: The last traded price at the end of the prior regular session.
Day high / low: The highest and lowest executed trade prices during the current session.
52-week high / low: The highest and lowest trade levels over the last 52 weeks — useful for measuring longer-term volatility.
Volume: The total number of shares traded during the reporting period (daily volume for a session).
Average volume: The average daily traded volume over a specified window (e.g., 30- or 90-day average) — helpful for assessing liquidity.
Market capitalization (market cap): The total equity value calculated as share price × total outstanding shares; a common measure of company size.

Each of these fields helps investors and traders interpret the Regeneron stock price in context. For example, a high intraday volume with a large price move suggests conviction behind the move.

Real-time and public data sources

You can obtain Regeneron stock price quotes and charts from several types of sources. Understand the difference between delayed public feeds and exchange-provided real-time feeds.

Official company channels: Regeneron investor relations publishes stock information and historical price lookup tools that reference official corporate filings and summaries.
Financial news and portal services: major sites provide quotes, charts, analyst coverage, and news. Many show delayed data unless they state real-time or you have a data subscription.
Brokerage platforms: most brokerages provide real-time quotes to customers and allow trading; Bitget also provides market access and price data for supported markets.

As of 2026-01-27, according to Regeneron Investor Relations and Yahoo Finance, the Regeneron stock price and related market-data fields (market cap and trading volume) are updated regularly on those platforms; users should consult those sources for the exact live figures on the date of interest.

Notable sources (examples)

Regeneron Investor Relations (official): company filings, press releases, and stock information.
Google Finance: quotes and charts for REGN.
Yahoo Finance: comprehensive quote pages with historical data and metrics.
CNBC and MarketWatch: news, analyst commentary, and quote snapshots.
Broker platforms: Robinhood-style apps provide retail access and streaming quotes for customers.

Note: this article references these well-known data sources by name. To verify the latest Regeneron stock price, open the source of your choice and check whether the quoted price is real-time or delayed.

Historical price and performance

Viewing historical prices

Historical data can be viewed in daily, weekly, or monthly intervals. This helps quantify volatility, trends, and support/resistance levels.
Use downloadable CSVs or built-in charting tools on financial portals or broker platforms to analyze price history for REGN.

Performance metrics

Price returns: analyze cumulative price returns over 1-month, 3-month, 1-year, 5-year, and longer horizons.
Total return: includes price appreciation plus dividends (if any) and is the preferred long-term performance measure.
Volatility and drawdowns: measure standard deviation of returns and peak-to-trough declines to understand risk.

Tools for historical lookup and charting

Most finance portals offer interactive charts with multiple timeframes and technical overlays (moving averages, RSI, MACD).
For rigorous analysis, download historical OHLCV (open, high, low, close, volume) data and perform calculations in a spreadsheet or analysis tool.

Historic milestones

All-time highs and lows: identify the dates when REGN reached its 52-week and all-time high or low. These milestones are often tied to major product news or macro regimes.
Material corporate actions: stock splits, reverse splits, large secondary offerings, or major M&A transactions change the share count or capital structure and must be adjusted for in historical charts.
Regulatory and product-impact events: emergency use authorizations, major clinical readouts, or legal rulings that materially affected Regeneron historically will show clear signatures in the Regeneron stock price charts.

When reviewing historical performance, always check whether price series are adjusted for splits and corporate actions.

Factors affecting Regeneron’s stock price

The Regeneron stock price is sensitive to both company-specific and broader market influences. Key drivers include:

Product approvals and clinical trial results: regulatory approvals or negative trial outcomes for pipeline candidates can cause large moves in REGN.
Sales performance of key drugs: revenue growth (or decline) for cornerstone products such as Dupixent and Eylea impacts earnings expectations.
Earnings reports: quarterly results, guidance updates, and management commentary shape near-term valuations.
Partnerships and licensing deals: collaborations that expand commercial reach or de-risk development can influence investor sentiment.
M&A activity: acquisition announcements or rumors can shift the stock price depending on perceived strategic fit and deal terms.
Macro factors: interest rates, broader market risk appetite, and sector rotation can amplify or dampen pharmaceutical stocks' moves.
Sector and peer news: changes affecting the biotech and pharmaceutical sector often influence REGN due to comparable valuation shifts.

Regulatory and clinical catalysts

FDA decisions, advisory committee recommendations, and clinical trial readouts are among the most material catalysts for Regeneron. Positive outcomes (e.g., approval, label expansion) can lift the Regeneron stock price, while setbacks (e.g., failed trials or safety concerns) often trigger declines.

Regulatory timelines and preannounced data-readout windows are frequently monitored by analysts and traders because these events can produce outsized intraday moves in REGN.

Financials and valuation metrics

Key metrics investors evaluate when assessing the Regeneron stock price include:

Revenue and revenue growth: top-line performance, particularly for flagship drugs, underpins earnings expectations.
Earnings per share (EPS): reported GAAP and non-GAAP EPS show profitability per share and are central to valuation.
Price-to-earnings (P/E) ratio: market price divided by EPS—used to compare valuation versus peers and historical norms.
EBITDA and operating margins: measures of operating profitability that help assess the earnings quality.
Cash position and debt: balance sheet strength matters for funding R&D and returning capital to shareholders.
Market capitalization: the aggregate equity value that places Regeneron within market cap-based indices.

Valuation context: investors compare these metrics to other large-cap biotech and pharmaceutical peers to determine whether the Regeneron stock price reflects a premium or discount for growth prospects and risk.

Dividends, buybacks and corporate actions

Dividend policy

Historically, many large biopharma firms prioritize R&D and share buybacks over dividends. Regeneron’s dividend policy should be checked in its investor relations materials for current status and historical payments.

Share repurchases and capital allocation

Repurchase programs reduce outstanding share count and can be supportive of the Regeneron stock price if executed at accretive levels.
Corporate actions such as secondary offerings, convertible issuance, or reorganizations also influence share count and per-share metrics.

Stock splits and adjustments

Any stock split or reverse split must be applied to historical price series when computing long-term returns.

Analyst coverage and price targets

Analyst activity

REGN is typically covered by multiple sell-side and independent analysts who publish ratings (buy/hold/sell) and price targets.
Analyst revisions following earnings reports, regulatory news, or trial readouts can cause short- to medium-term moves in the Regeneron stock price.

Interpreting targets and ratings

Consensus price targets and rating distributions offer an aggregated view of market expectations but are not guarantees. They may lag fast-moving news.

News, events and investor calendar

Important items that regular users should track to anticipate potential volatility in the Regeneron stock price:

Quarterly earnings releases and conference calls
FDA and other regulatory submission timelines
Clinical trial readouts and investigator-initiated study updates
Investor presentations and attendance at major conferences (for example, large healthcare or investor conferences)
SEC filings and proxy statements

As of 2026-01-27, according to company disclosures on Regeneron Investor Relations, the investor calendar lists upcoming quarterly results and conference presentations; be sure to consult the official calendar for precise dates and times.

Market trading characteristics and risks

Liquidity and intraday volatility

REGN is typically a highly liquid large-cap biotech stock, but volume and volatility can spike around catalysts.
High option activity around earnings or regulatory events can increase implied volatility in derivative markets.

Common trading strategies

Long-term investors focus on fundamentals, pipeline prospects, and total return.
Traders may use event-driven strategies around earnings or trial readouts, momentum strategies, or technical setups based on support/resistance.

Principal risks

Clinical and regulatory risk: failed trials or regulatory setbacks can materially lower the Regeneron stock price.
Commercial competition: competing drugs or price pressure in key therapeutic areas can affect revenue forecasts.
Patent and IP challenges: litigation or generic competition may erode future cash flows.
Macro and market risk: broader market sell-offs and rising yields can depress valuations across the sector.

Always consider risk tolerance and timeframe when evaluating the Regeneron stock price.

How to track and interpret price movements

Practical steps

Use the official Regeneron investor relations page for corporate filings and event calendars to line up material catalysts with price action.
For streaming price data, use a broker-provided real-time feed or Bitget’s market interface if REGN trading is supported on the platform.
Check whether quotes are real-time or delayed on public portals; delayed quotes are typically labeled and lag by 15–20 minutes.

Interpreting charts and indicators

Timeframes: short-term intraday charts (1–30 minutes) are for traders; daily, weekly, and monthly charts are for investors.
Indicators: simple moving averages, RSI, and volume analysis help interpret momentum and conviction behind moves in the Regeneron stock price.
Confirm signals: combine technical signals with fundamental context—e.g., a breakout on high volume with positive earnings commentary has different implications than a breakout on low volume.

Verification and data hygiene

Cross-check quotes across two or more authoritative sources before making trading decisions. Ensure the data source indicates whether it is real-time.
For official filings and precise historical adjustments, refer to Regeneron’s SEC filings and investor relations materials.

References and external links

Primary data and reference pages to consult for the Regeneron stock price and company information (search by name on your preferred platform):

Regeneron Investor Relations — Stock Information / Historic Price Lookup (official company site)
Yahoo Finance — REGN quote and historical data
Google Finance — REGN quote and charting
CNBC — REGN company page and news
MarketWatch — REGN stock page and market data
Seeking Alpha — analyst coverage and articles

As of 2026-01-27, according to Regeneron Investor Relations and Yahoo Finance, the platforms listed above provide up-to-date quotes and historical charts for REGN; please consult these named sources directly to view the exact Regeneron stock price and supporting metrics on your date of interest.

Further exploration and action

If you want to follow the Regeneron stock price closely, add REGN to a watchlist on your preferred financial platform or trading app. For those seeking an integrated trading and data experience, explore Bitget’s market interface and Bitget Wallet to manage positions and track REGN alongside other assets. Always verify whether the platform provides real-time data or delayed quotes before making time-sensitive decisions.

Note on data accuracy and neutrality

This article presents neutral, factual guidance about the Regeneron stock price and related market-data topics. It is not investment advice. For precise, timestamped numerical values (market capitalization, intraday volume, or last trade price) check the live quotes and official filings from the sources listed in the References section.

More practical tips

Set alerts: configure price-motion or news alerts for REGN so you are notified of major moves or announcements.
Confirm event windows: track FDA advisory committee dates and company event calendars—these often drive large moves in the Regeneron stock price.
Use multiple sources: cross-verify price and volume across at least two reputable providers.

Further exploration

To explore more about REGN and similar biotech stocks, browse the company’s investor presentations and recent SEC filings, and monitor coverage in the financial press. Use Bitget’s tools for portfolio tracking and trade execution where available.

References cited in this article are publicly available via the listed sources and official company communications. As of 2026-01-27, check those sources for the latest quantifiable figures on market cap, average daily volume, and other metrics.

The content above has been sourced from the internet and generated using AI. For high-quality content, please visit Bitget Academy.